4.6 Editorial Material

Outcomes of the ACT III Study: Rindopepimut (CDX-110) Therapy for Glioblastoma

Journal

NEUROSURGERY
Volume 76, Issue 6, Pages N17-N17

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1227/01.neu.0000465855.63458.0c

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available